Neurological development of children born to liver transplant recipients

J Schreiber-Zamora1, B Kociszewska-Najman1, B Borek-Dzięcioł1

  • 1Division of Neonatology, 1st Department of Obstetrics and Gynecology, Medical University of Warsaw, Poland.

Insights

Children born to mothers who received liver transplants show normal neurological development, similar to those in a control group. This indicates immunosuppressive treatment during pregnancy does not negatively impact child neurodevelopment.

Area of Science:

  • Pediatric Neurology
  • Transplant Medicine
  • Obstetrics

Background:

  • Immunosuppressive therapy in pregnant liver transplant recipients (LTRs) raises concerns about potential adverse effects on fetal development.
  • Assessing the long-term neurological outcomes in children born to LTRs is crucial for understanding the safety of such treatments during pregnancy.

Purpose of the Study:

  • To conduct a neurological assessment of infants and children born to liver transplant recipients.
  • To compare the neurological development of children born to LTRs with a control group of children born to non-recipients.

Main Methods:

  • A cohort of 88 children was studied: 44 born to LTR mothers and 44 to non-recipients, matched for gestational age.
  • Neurological examinations were performed on children aged 7 weeks to 10 years by a pediatric neurologist.
  • Statistical analysis utilized the Fisher's exact test to compare developmental outcomes.

Main Results:

  • Normal neurological development was observed in 79.54% of children in the LTR group and 88.63% in the control group (P = .3827).
  • Slight neurological disorders were present in 13.63% of the LTR group and 11.36% of the control group.
  • Moderate disorders were found in 6.81% of the LTR group; no severe disorders were noted in either group.

Conclusions:

  • Neurological development in children born to mothers who underwent liver transplantation is comparable to that of children from mothers without organ transplants.
  • Chronic immunosuppressive treatment during fetal life does not appear to adversely affect the neurological development of offspring.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
786
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
1.3K
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
608
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373